- Mechanical Circulatory Support Devices
- Cardiac Arrest and Resuscitation
- Cardiac Structural Anomalies and Repair
- Cardiac Imaging and Diagnostics
- Cardiac Valve Diseases and Treatments
- Acute Myocardial Infarction Research
- Infective Endocarditis Diagnosis and Management
- Trauma and Emergency Care Studies
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Health Systems, Economic Evaluations, Quality of Life
Leipzig Heart Institute
2024-2025
German Centre for Cardiovascular Research
2025
Leipzig University
2024
University Hospital Leipzig
2024
University of Lübeck
2016
University Hospital Schleswig-Holstein
2016
Abstract Background and Aims Glycoprotein (GP) IIb/IIIa inhibitors are recommended in acute myocardial infarction (AMI) for bailout treatment case of angiographic microvascular obstruction (MVO), also termed no-reflow phenomenon, after percutaneous coronary intervention (PCI) with, however, lacking evidence (class IIa, level C). Methods The investigator-initiated, international, multicenter REVERSE-FLOW trial randomized 120 patients with AMI Thrombolysis In Myocardial Infarction flow grade...
OBJECTIVES: Existing scores for risk stratification after out-of-hospital cardiac arrest (OHCA) are either medically outdated, limited to registry data, small cohorts, and certain healthcare systems only, or include rather complex calculations. The objective of this study was develop an easy-to-use prediction score short-term mortality in patients with successfully resuscitated OHCA without ST-segment elevation on the post-resuscitation electrocardiogram, derived from Angiography...
Abstract Aims We analysed consecutive patients with acute myocardial infarction complicated by cardiogenic shock (CS) who were enrolled into the CULPRIT-SHOCK randomized controlled trial (RCT) and those exclusion criteria included accompanying registry. Methods results In total, 1075 infarct-related CS screened for in 83 specialized centres Europe; 369 of them had RCT Patients followed over 1 year. The mean age was 68 years 260 (25%) women. 13.5%, 30.9%, 55.6% one-vessel, two-vessel,...
Introduction The aim of this study was to analyze age-associated myocardial injury and clinical outcome after non-ST-elevation infarction (NSTEMI). Methods This prospective, multicenter consists 440 patients with NSTEMI enrolled at 7 centers. All were treated primary percutaneous coronary intervention underwent cardiac magnetic resonance (CMR) imaging 1–10 days inclusion. CMR parameters evaluated by creating 2 subgroups: <80 years vs. ≥80 years. endpoint the 1-year incidence major...